Dec 31, 2012

ANI Pharmaceuticals Q4 2012 Earnings Report

Total Revenue
$5.32M
Previous year: $114K
+4552.7%
EPS
-$1.27
Previous year: -$0.52
+144.2%
Gross Profit
-$907K
Previous year: $64.4K
-1509.1%
Cash and Equivalents
$11K
Free Cash Flow
-$641K
Total Assets
$13.7M
Previous year: $62.4M
-78.0%

ANI Pharmaceuticals

ANI Pharmaceuticals